Rome Therapeutics

OverviewSuggest Edit

Rome Therapeutics is a company that develops therapies created to cure cancer and autoimmune diseases. The company uses repeatome therapy for its research and development processes enabling to help patients fight cancer.

Latest Updates

Employees (est.) (Sept 2021)31(+4%)
Cybersecurity ratingAMore

Key People/Management at Rome Therapeutics

Rosana Kapeller

Rosana Kapeller

Co-Founder, President and CEO, Director
Christine Loggins

Christine Loggins

Senior Vice President, Strategy and Operations
Dennis Zaller

Dennis Zaller

Chief Scientific Officer
Donna Romero

Donna Romero

Senior Vice President, Chemistry
Kira Nelson

Kira Nelson

Vice President, Finance
Wenyan Miao

Wenyan Miao

Vice President, Biology and Preclinical Development
Show more

Rome Therapeutics Office Locations

Rome Therapeutics has an office in Cambridge
Cambridge, MA, US
700 Main St
Show all (1)

Rome Therapeutics Financials and Metrics

Summary Metrics

Founding Date


Rome Therapeutics total Funding

$50 m

Rome Therapeutics latest funding size

$50 m

Time since last funding

a year ago

Rome Therapeutics investors

Rome Therapeutics's latest funding round in April 2020 was reported to be $50 m. In total, Rome Therapeutics has raised $50 m
Show all financial metrics

Rome Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Rome Therapeutics Online and Social Media Presence

Embed Graph

Rome Therapeutics News and Updates

GV joins $50 million round in Rome Therapeutics to research ‘junk DNA’ for cancer therapies

Rome Therapeutics, a biotechnology startup that’s using machine learning (ML) to explore the human genome and develop new treatments for cancer and autoimmune diseases, has launched out of stealth today with $50 million in series A funding from GV, Arch Venture Partners, and Partners Innovation Fund…

Rome Therapeutics Frequently Asked Questions

  • When was Rome Therapeutics founded?

    Rome Therapeutics was founded in 2020.

  • Who are Rome Therapeutics key executives?

    Rome Therapeutics's key executives are Rosana Kapeller, Christine Loggins and Dennis Zaller.

  • How many employees does Rome Therapeutics have?

    Rome Therapeutics has 31 employees.

  • Who are Rome Therapeutics competitors?

    Competitors of Rome Therapeutics include Memgen, APAC Biotech and Ectin Research.

  • Where are Rome Therapeutics offices?

    Rome Therapeutics has an office in Cambridge.

  • How many offices does Rome Therapeutics have?

    Rome Therapeutics has 1 office.